Print

Interleukin Genetics Inc. (ILGN) Reports Second Quarter 2013 Financial Results  
8/15/2013 6:54:44 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Interleukin Genetics, Inc. (OTCQB: ILIU) today issued financial and operational results for the second quarter ended June 30, 2013.

Revenue for the quarter ended June 30, 2013 was $852,000, compared to $799,000 for the same period in 2012. The increase is primarily attributable to increased genetic testing revenue recognized from genetic tests processed as a result of sales through the Amway sales channel.

Hey, check out all the research scientist jobs. Post your resume today!

//-->